Aug 5, 2026 06:50AM
Aug 5, 2026 06:50AM
Jul 29, 2026 06:50AM
Jul 29, 2026 06:50AM
May 21, 2026 06:40AM
May 19, 2026 04:30PM
May 19, 2026 04:30PM Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
May 14, 2026 04:05PM
May 1, 2026 06:50AM
May 1, 2026 06:50AM
Apr 27, 2026 06:50AM
Apr 27, 2026 06:50AM
Mar 19, 2026 04:05PM
Mar 2, 2026 07:27AM Eton Pharmaceuticals acquires HEMANGEOL commercialization rights
Mar 2, 2026 07:27AM
Feb 25, 2026 01:47PM
Feb 25, 2026 01:47PM
Feb 2, 2026 06:51AM
Feb 2, 2026 06:50AM
Nov 6, 2025 04:05PM
Aug 7, 2025 04:05PM Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results
Jul 8, 2025 06:50AM
Jul 8, 2025 06:50AM
May 29, 2025 06:52AM
May 28, 2025 05:31PM
May 28, 2025 05:28PM
May 13, 2025 04:01PM
Apr 28, 2025 06:50AM Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
Mar 18, 2025 06:50AM
Mar 14, 2025 06:52AM
Mar 14, 2025 06:50AM
Mar 3, 2025 06:50AM
Mar 3, 2025 06:50AM
Feb 7, 2025 06:50AM
Feb 6, 2025 06:50AM Eton Pharmaceuticals (ETON) Announces Extension of PDUFA Goal Date for ET-400
Feb 6, 2025 06:50AM
Jan 24, 2025 06:39AM
Jan 6, 2025 07:06AM
Jan 3, 2025 06:50AM
Jan 3, 2025 06:50AM
Dec 20, 2024 06:51AM
Dec 20, 2024 06:50AM Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
Dec 17, 2024 06:51AM
Dec 17, 2024 06:50AM
Nov 26, 2024 06:59AM
Nov 25, 2024 06:51AM
Nov 25, 2024 06:50AM
Nov 12, 2024 04:01PM
Nov 7, 2024 07:00AM Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)
Oct 17, 2024 04:18PM

327,645 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All